EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

First report of KPC-35-producing Klebsiella pneumoniae ST258 isolated in Peru

Arturo Gonzales-Rodriguez, Juan Carlos Gómez-de-la-Torre, Luis Alvarado, Edgar Gonzales Escalante

Revista Argentina de Microbiología · 2025

DOI: 10.1016/j.ram.2024.10.008 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Revista Argentina de Microbiología, 2025. Verfasst von Arturo Gonzales-Rodriguez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Piura, Facultad de Medicina Humana, Lima, Peru. Electronic address: arturo.gonzales@udep.edu.pe. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, beta-Lactamases, Klebsiella Infections, Bacterial Proteins. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Klebsiella pneumoniae sequence type 258 (ST258) is the main cause of the global spread of KPC and a significant public health problem. In 2015, ceftazidime/avibactam (CZA) was introduced as a therapeutic alternative and since it has contributed to the development of new KPC variants. Here we present the identification of two consecutive isolations of K. pneumoniae ST258 (KP1 and KP2), from a patient with urinary tract infection. KP1 and KP2 harbored blaKPC-2 and blaKPC-35, respectively. KP2 exhibited a modified susceptibility profile to carbapenems and resistance to CZA. To the best of our knowledge, this is the first report of K. pneumoniae ST258 in Peru, which highlights the increasing problem of CZA resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaebeta-LactamasesKlebsiella InfectionsBacterial ProteinsPeruHumansMicrobial Sensitivity TestsUrinary Tract InfectionsCeftazidimeMaleAnti-Bacterial AgentsDrug CombinationsDrug Resistance, Multiple, BacterialAzabicyclo Compounds

Stichwörter der Autor:innen

Drug resistanceKlebsiella pneumoniaePeruPerúResistencia a los antimicrobianos

Substanzen

beta-LactamasesBacterial ProteinsCeftazidimeAnti-Bacterial AgentsDrug Combinationsavibactam, ceftazidime drug combinationAzabicyclo Compounds

Autor:innen und Institutionen

  • Universidad de Piura, Facultad de Medicina Humana, Lima, Peru. Electronic address: arturo.gonzales@udep.edu.pe.
  • Laboratorio Clínico Roe, Lima, Peru.
  • Universidad de Piura, Facultad de Medicina Humana, Lima, Peru.

Zitieren

APA

Gonzales-Rodriguez, A., Gómez-de-la-Torre, J. C., Alvarado, L., & Gonzales Escalante, E. (2025). First report of KPC-35-producing Klebsiella pneumoniae ST258 isolated in Peru. Revista Argentina de Microbiología. https://doi.org/10.1016/j.ram.2024.10.008

Vancouver

Gonzales-Rodriguez A, Gómez-de-la-Torre JC, Alvarado L, Gonzales Escalante E. First report of KPC-35-producing Klebsiella pneumoniae ST258 isolated in Peru. Revista Argentina de Microbiología. 2025. doi:10.1016/j.ram.2024.10.008

BibTeX
@article{GonzalesRodriguez2025,
  author = {Gonzales-Rodriguez, Arturo and Gómez-de-la-Torre, Juan Carlos and Alvarado, Luis and Gonzales Escalante, Edgar},
  title = {First report of KPC-35-producing Klebsiella pneumoniae ST258 isolated in Peru},
  journal = {Revista Argentina de Microbiología},
  year = {2025},
  doi = {10.1016/j.ram.2024.10.008}
}
Kostenlos starten →